2022
DOI: 10.1007/s00216-022-04261-7
|View full text |Cite
|
Sign up to set email alerts
|

Generation of bioluminescent enzyme immunoassay for ferritin by single-chain variable fragment and its NanoLuc luciferase fusion

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 27 publications
0
3
0
Order By: Relevance
“…When the same amount of the nanobody–NanoBiT fusion protein was used, a weaker signal was observed with increasing volume. This outcome may be due to the increasing volume of the buffer, which can cause a signal decline in the system . To obtain the strongest signal, 10 μL of immune reagents, 10 μL of the substrate solution, and 10 μL of samples were selected for further analysis.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…When the same amount of the nanobody–NanoBiT fusion protein was used, a weaker signal was observed with increasing volume. This outcome may be due to the increasing volume of the buffer, which can cause a signal decline in the system . To obtain the strongest signal, 10 μL of immune reagents, 10 μL of the substrate solution, and 10 μL of samples were selected for further analysis.…”
Section: Resultsmentioning
confidence: 99%
“…The nanoluciferase reporter gene has been widely used in developing immunoassays in a conventional sandwich ELISA for protein determination. The nanoluciferase can split into a nonfunctional large binary subunit (LgBiT) and a small binary subunit (SmBiT) and reassemble and recover the enzymatic activity when approaching. Two nanobodies that had been previously used to successfully establish a double nanobody sandwich ELISA were chosen as the model to generate the homogeneous split-luciferase assay.…”
Section: Resultsmentioning
confidence: 99%
“…ScFv, including IgY-scFv, has the advantages of easy penetration into the target tissue, low side effects, high specificity, and high purity; therefore, it has a great biomedical potential of being widely used in clinic [3,8]. Particularly, avian IgY-scFv can fuse to alkaline phosphatase for the detection of aspergillus pathogens [9] and fuse to NanoLuc luciferase for the detection of ferritin [10]. Therefore, IgY-scFv can bind to the corresponding antigen in the target tissue of the host, thereby leading to enhanced diagnostic and therapeutic effects.…”
Section: Introductionmentioning
confidence: 99%